Malin Corporation | MLC - Net Income


Malin Corporation reported EUR-1.1M in Net Income for its fiscal semester ending in December of 2023.





Net Income Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -1.16M 417K Sep/2025
ALKERMES USD 82.76M 4.34M Sep/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Eurofins Scientific SE EUR 216M 29.8M Jun/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
IQVIA Holdings USD 514M 183M Dec/2025
Lonza CHF 307M 22M Dec/2024
Malin Corporation EUR -1.1M 2.2M Dec/2023
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Ovoca Bio EUR -5.65M 3.28M Jun/2022
Revvity USD 98.36M 51.71M Dec/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -128.2M 123.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025